US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Overview
Desktop
Wall Street JournalC
CVKD
Cadrenal Therape
7.83
-0.22-2.73%After Hours: 7.81 -0.02 -0.26%18:06 09/06 EDT
OPEN/PREV CLOSE7.74/8.05
TODAY RANGE7.67-7.92
VOL14.11K
MARKET CAP8.36M
52 WEEK RANGE0.3600-32.55
AVG VOL (3M)19.96K
% TURNOVER1.32%
TURNOVER--
P/E (TTM)-9.2020
% RANGE3.85%
EPS(TTM)-0.8509
P/E(FORWARD)-21.7500
P/B-11.5572
BVPS-0.6775
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP4.45M
SHARES OUTSTANDING1.07M
NEXT EARNINGS--
FREE FLOAT568.58K
LOT SIZE1
EX-DIV DATE08/20/2024
News
Press Releases
Financial Reports
Profile
Press release·08/09 00:43
Cadrenal Therape: Current report
Press release·08/08 10:15
Based on the provided financial report, the title of the article is: "QUARTERLY REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2024
Benzinga·08/07 20:35
Cadrenal Therapeutics Q2 EPS $(0.15) Misses $(0.08) Estimate
Seeking Alpha·08/06 14:50
Abbott to collaborate with Cadrenal on anticoagulant tecarfarin
TipRanks·08/06 13:29
Cadrenal Therapeutics Partners with Abbott on Cardiac Trial
TipRanks·07/31 20:43
Cadrenal Therapeutics Enhances Incentives and Adjusts Stock Plan
Press release·06/11 22:16
Cadrenal Therape: Other definitive proxy statementsOpen document
Benzinga·05/20 20:31
12 Health Care Stocks Moving In Monday's After-Market Session
Press release·05/10 06:51
Cadrenal Therapeutics, Inc. Quarterly Report on Form 10-Q for the Quarterly Period Ended March 31, 2024
Same Industry
Name/Symbol
Change%
Price